InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
Provided By Globe Newswire
Last update: Sep 13, 2022
VANCOUVER, British Columbia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced the closing of its previously announced private placement with two healthcare-focused institutional investors for the issuance and sale of 691,245 of its common shares at a purchase price of $8.68 per share (or pre-funded warrant in lieu thereof) priced at-the-market under Nasdaq rules. In addition, the Company has issued to the investors in the offering unregistered preferred investment options (the “investment options”) to purchase up to an aggregate of 1,382,490 common shares.
2.75
-0.07 (-2.48%)
Find more stocks in the Stock Screener
INM Latest News and Analysis
18 days ago - ChartmillHere are the top movers in Tuesday's session.Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
18 days ago - ChartmillCurious about the most active stocks on Tuesday?Get a pulse on the US markets on Tuesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
18 days ago - ChartmillLet's have a look at the top gainers and losers in the middle of the day of today's session.Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
18 days ago - ChartmillWhich stocks are gapping on Tuesday?Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.
18 days ago - ChartmillTuesday's pre-market session: top gainers and losersDiscover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
